MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 52328-98-0
MCE 国际站:Dimethylcurcumin
产品活性:Dimethylcurcumin (ASC-J9) 是一种雄激素受体降解增强剂,可有效抑制耐药性前列腺癌细胞增殖和侵袭。
研究领域:Vitamin D Related/Nuclear Receptor
作用靶点:Androgen Receptor
结构分类:苯丙素类 | 简单苯丙素
来源:植物 | 姜科 | 姜
In Vitro: Dimethylcurcumin (ASC-J9) is able to degrade fAR and AR3 in a dose-dependent manner in various human PCa cells. Dimethylcurcumin (ASC-J9) can also effectively suppress AR-targeted genes in CWR22Rv1-fARKD cells. Dimethylcurcumin (ASC-J9) (5 or 10 µM) significantly suppresses the DHT-induced cell growth in all three PCa cell lines. Dimethylcurcumin (ASC-J9) suppresses AR-targeted genes and cell growth by degradation of fAR and ectopic AR3 in C81 and C4-2 cells. Dimethylcurcumin (ASC-J9) selectively promotes AR degradation by disrupting the interaction between AR and AR coregulators. ASC-J9 reduces the AR aggregated AR-112Q in cells. Dimethylcurcumin (ASC-J9) suppresses the aggregation of AR-112Q in SBMA PC12/AR-112Q cells.
In Vivo: Dimethylcurcumin (ASC-J9) (75 mg/kg, i.p.) degrades both fAR and AR3 in the xenografted tumors in vivo, and SC-J9-treated tumors has significantly decreased Ki67-positive cells. Dimethylcurcumin (ASC-J9) (50 mg/kg every 48 h, i.p.) substantially ameliorates the SBMA symptoms in AR-97Q mice, and ameliorates neuromuscular pathological findings. The Dimethylcurcumin (ASC-J9)-treated SBMA mice have relatively normal serum testosterone concentrations. ASC-J9-treated mice show significantly smaller prostate tumor sizes when compared with those receiving classic ADT/castration with little serum androgen.
相关产品:Natural Product Library Plus | Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Natural Product Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Medicine Food Homology Compound Library | Traditional Chinese Medicine Active Compound Library | Transcription Factor-Targeted Library | Rare Diseases Drug Library | Anti-Cancer Natural Product Library | Plant-Sourced Natural Product Library | Anti-Prostate Cancer Compound Library | Nuclear Receptor Compound Library | Medroxyprogesterone acetate-d3 | Androgen receptor antagonist 4 | VPC-13789 | Acetyl-ACTH (7-24) (human, bovine, rat) | CSRM617 hydrochloride | Ar-V7-IN-1 | Acetyl-ACTH (3-24) (human, bovine, rat) | Cyproterone acetate-d3 | TD-802 | GTx-007 | RD162 | MK-4541 | S-23 | MI-136 | MK-3984 | Boc-Glycine-2-13C | SK33 | Brassicasterol | Medroxyprogesterone acetate | Apalutamide-d3 | Cyprodinil | Linuron | ARV-766 | DHEA | CLP-3094 | AR antagonist 2 | Prochloraz | D4-abiraterone | Spironolactone-d3-1
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。